ÂÜÀòÂÒÂ×

Charmaine O'Neill has extensive experience in clinical operations within the biopharmaceutical industry, currently serving as Vice President of Clinical Operations at Vantage Biosciences since August 2024. Previously, O'Neill held positions at Gyroscope Therapeutics as Global Trials Director and Associate Director of Clinical Operations, contributing to the company's clinical project management efforts. O'Neill's background includes significant roles at Aimmune Therapeutics, where the focus was on developing desensitization treatments for food allergies, and various leadership positions at hVIVO Ltd., specializing in respiratory viral disease studies. With a strong foundation in project management for clinical trials and expertise in managing complex studies across diverse therapeutic areas, O'Neill holds a BSc (Hons) in Pharmacology from Liverpool University and a BSc (Hons) in Psychology from London Metropolitan University, along with a Diplome en la langue francaise from Universite de Reims.